Insmed Inc. buy Truist Financial Co.
Start price
14.08.25
/
50%
€110.00
Target price
14.08.26
€118.68
Performance (%)
-19.99%
Price
30.07.26
€89.87
Summary
This prediction is currently active. The price of Insmed Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -19.99%. This prediction currently runs until 14.08.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -4.455% | -4.455% |
| iShares Core DAX® | 3,90 % | 2,67 % |
| iShares Nasdaq 100 | -2,60 % | -7,93 % |
| iShares Nikkei 225® | -0,54 % | -9,75 % |
| iShares S&P 500 | -0,88 % | -1,49 % |
Comments by Truist_Financial_Co_ for this prediction
In the thread Insmed Inc. diskutieren
Insmed, Inc. (NASDAQ: INSM) had its price target raised by analysts at Truist Financial Corporation from $126.00 to $139.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat

